November 10, 2023 11:16 AM EST

Vor shares new data for stem cell therapy; Melinta partners with Venatorx on antibiotic under FDA review

Plus, news about BeiGene, Zymeworks, Rznomics, and Adicet:

Vor Bio shares early data for its gene-edited stem cell therapy: The company

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Vor shares new da­ta for stem cell ther­a­py; Melin­ta part­ners with Ve­na­torx on an­tibi­ot­ic un­der FDA re­view